Pt. Murphy et al., AUDIT OF PATIENTS ON ORAL ANTICOAGULANTS WITH INTERNATIONAL NORMALIZED RATIOS OF 8 OR ABOVE, Clinical and laboratory haematology, 20(4), 1998, pp. 253-257
We reviewed retrospectively the medical records of all patients (n = 7
7, mean age 74.2) on oral anticoagulants with an International normali
zed ratio (INR) of eight or above in a 12-month period in the Leiceste
rshire District Health Authority (DHA). From a total of 55 625 INRs, 1
31 (0.24%) were greater than or equal to 8. A major cause of over-anti
coagulation was unsatisfactory dose loading during in-hospital commenc
ement of oral anticoagulation. The incidence of major bleeding was 12.
9% of total episodes of INR greater than or equal to 8 with two haemor
rhage-related fatalities. Therapy of major haemorrhage with fresh froz
en plasma (FFP) and intravenous (i.v.) vitamin K proved effective but
was not given in a majority of such cases. In conclusion, improvements
in initial dose Loading of oral anticoagulation and in the management
of major haemorrhage are required. Severely over-anticoagulated patie
nts without obvious bleeding should nevertheless receive small dose vi
tamin It therapy to reduce the risk of haemorrhage related morbidity a
nd mortality without compromising subsequent oral anticoagulant contro
l.